Copayments turn older women off to mammography
Copayments may make financial sense for insurers, but mammographers are appalled that some older women are avoiding routine screening because their Medicare managed-care plans force them to pony up for a portion of the imagingprocedure.
Dr. Amal Trivedi and colleagues at Brown University uncovered the pattern as they reviewed coverage for 174 Medicare managed-care plans and screening mammography utilization for those plans’ beneficiaries, more than 550,000 women aged 65 to 69. The study was published in the Jan. 24 New England Journal of Medicine (2008:358[4]:375-383).
They found that the number of Medicare managed-care plans that required a copayment of at least $12.50 (range: $12.50 to $35) or coinsurance of more than 10% for screening mammography increased from three plans in 2001 to 21 plans in 2004.
And the percentage of women who took advantage of Medicare’s biennial coverage of screening mammography decreased. Among plans that required cost sharing, the biennial breast cancer screening rates were 8.3 percentage points lower than for Medicare managed-care plans that provided full coverage (77.5% for full coverage versus 69.2% for cost-shared plans). Biennial screening mammography increased 3.4% in the four-year study period for women who participated in the plans that did not require copayments or coinsurance.
The findings were troubling for Dr. Carol H. Lee, chair of the American College of Radiology’s breast imaging commission.
“We are taking a segment of the population in whom the test works best and adding a disincentive to getting it. Given limited healthcare resources and limited dollars, perhaps this is not the best place to save money,” she said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.